We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
China Health Industries Holdings Inc (QB) | USOTC:CHHE | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.92 | 1.20 | 1.95 | 0.00 | 21:30:12 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of Registrant as specified in its Charter)
(State or other jurisdiction of incorporation) |
(Commission File No.) |
(IRS Employer Identification No.) |
People’s Republic of
(Address of principal executive offices) (Zip Code)
(Registrant’s Telephone Number)
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange
Act of 1934 (17 CFR 240.12b-2)
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
ITEM 4.01. | CHANGES IN REGISTRANT’S CERTIFYING ACCOUNTANT. |
On October 23, 2023, the Board of Directors of China Health Industries Holdings, Inc., a corporation incorporated under the laws of the State of Delaware (the “Company”) approved the dismissal of ARK Pro CPA & Co. (“ARK”) as the Company’s independent registered public accounting firm, effective immediately.
ARK was engaged on August 2, 2023, after the most recent fiscal year of the Company. As a result, there has been no report issued by ARK on any financial statements of the Company as of October 23, 2023.
During the period from August 2, 2023, the date on which ARK was engaged through October 23, 2023 (the “ARK Engagement Period”), there were no disagreements with ARK on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreement(s), if not resolved to the satisfaction of ARK, would have caused it to make reference to the subject matter of the disagreement(s) in connection with its report. During the ARK Engagement Period, there were no reportable events of the type described in Item 304(a)(1)(v) of Regulation S-K.
The Company provided ARK with a copy of the foregoing disclosure and requested ARK to furnish the Company with a letter addressed to the Securities and Exchange Commission stating whether it agrees with the statements made therein. A copy of such letter furnished by ARK is filed as Exhibit 16.1 to this Form 8-K.
On October 23, 2023, the Board of Directors of the Company approved the engagement of Assentsure PAC (“Assentsure”) as its new independent registered public accounting firm.
During the Company’s two most recent fiscal years and the subsequent interim period through October 23, 2023, neither the Company nor anyone on its behalf consulted with Assentsure regarding (i) the application of accounting principles to a specified transaction, either completed or proposed; the type of audit opinion that might be rendered on the Company's financial statements, and neither a written report nor oral advice was provided that Assentsure concluded was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue; or (ii) any matter that was either the subject of a disagreement (as defined in Item 304(a)(1)(iv) of Regulation S-K and its related instructions) or a reportable event (as described in Item 304(a)(1)(v) of Regulation S-K).
ITEM 9.01. | FINANCIAL STATEMENTS AND EXHIBITS. |
(d) Exhibits.
Exhibit No. | Description | |
16.1 | Letter from ARK Pro CPA & Co. dated October 24, 2023 | |
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CHINA HEALTH INDUSTRIES HOLDINGS, INC. | ||
Date: October 24, 2023 | /s/ Xin Sun | |
By: | Xin Sun | |
Title: | Chief Executive Officer and Chief Financial Officer (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) |
Exhibit 16.1
October 24, 2023
U.S. Securities & Exchange Commission
100 F Street, NE
Washington, DC 20549
U.S.A.
Ladies and Gentlemen:
We have read the statements concerning our firm contained in Item 4.01 of this Form 8-K of China Health Industries Holdings Inc. dated October 24, 2023 to be filed with the United States Securities and Exchange Commission and are in agreement with the statements concerning our firm in such report. We have no basis to agree or disagree with other statements contained therein.
Very truly yours
/s/ ARK Pro CPA & Co
ARK Pro CPA & Co
Hong Kong, China
Cover |
Oct. 23, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 23, 2023 |
Entity File Number | 000-51060 |
Entity Registrant Name | CHINA HEALTH INDUSTRIES HOLDINGS, INC. |
Entity Central Index Key | 0001309057 |
Entity Tax Identification Number | 86-0827216 |
Entity Incorporation, State or Country Code | DE |
Entity Address, Address Line One | 3199-1 Longxiang Road, Songbei District |
Entity Address, City or Town | Harbin City, Heilongjiang Province |
Entity Address, Country | CN |
Entity Address, Postal Zip Code | 150028 |
City Area Code | 86-451 |
Local Phone Number | 88100688 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Not Applicable |
Trading Symbol | Not Applicable |
Security Exchange Name | NONE |
Entity Emerging Growth Company | false |
1 Year China Health Industries (QB) Chart |
1 Month China Health Industries (QB) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions